These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23654124)

  • 1. [Immune to nicotine addiction?].
    Schumacher B
    MMW Fortschr Med; 2013 Mar; 155(5):22-3. PubMed ID: 23654124
    [No Abstract]   [Full Text] [Related]  

  • 2. A shot at quitting.
    Smith SD
    Minn Med; 2006 Sep; 89(9):9-10. PubMed ID: 17024915
    [No Abstract]   [Full Text] [Related]  

  • 3. Nicotine conjugate vaccines: A novel approach in smoking cessation.
    Kitchens CM; Foster SL
    J Am Pharm Assoc (2003); 2012; 52(1):116-8. PubMed ID: 22257625
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expecting the antinicotine vaccine].
    Didilescu C
    Pneumologia; 2009; 58(3):177-8. PubMed ID: 19817315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why a nicotine vaccine?
    Le Houezec J
    Clin Pharmacol Ther; 2005 Nov; 78(5):453-5. PubMed ID: 16321611
    [No Abstract]   [Full Text] [Related]  

  • 6. Could a novel vaccine help smokers quit?
    Kuehn BM
    JAMA; 2005 Aug; 294(8):891-2. PubMed ID: 16118374
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotine-Targeting Nano-Vaccines for Smoking Cessation.
    Desai RI; Bergman J
    Neuropsychopharmacology; 2016 Jan; 41(1):377-8. PubMed ID: 26657956
    [No Abstract]   [Full Text] [Related]  

  • 8. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.
    Zhao Z; Powers K; Hu Y; Raleigh M; Pentel P; Zhang C
    Biomaterials; 2017 Apr; 123():107-117. PubMed ID: 28167389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in vaccines against nicotine addiction].
    Wang GB; Zhu CJ
    Yao Xue Xue Bao; 2013 Aug; 48(8):1189-94. PubMed ID: 24187824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic vaccines for nicotine dependence.
    Maurer P; Bachmann MF
    Curr Opin Mol Ther; 2006 Feb; 8(1):11-6. PubMed ID: 16506520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines.
    Hu Y; Zhao Z; Harmon T; Pentel PR; Ehrich M; Zhang C
    Biomaterials; 2018 Nov; 182():72-81. PubMed ID: 30107271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers.
    Hatsukami DK; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR
    Clin Pharmacol Ther; 2005 Nov; 78(5):456-67. PubMed ID: 16321612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The vaccine against nicotine--the future for smoking cessation?].
    Mihăltan F
    Pneumologia; 2007; 56(2):101-3. PubMed ID: 18019757
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-nicotine abuse vaccines in the pipeline: an update.
    Cerny EH; Cerny T
    Expert Opin Investig Drugs; 2008 May; 17(5):691-6. PubMed ID: 18447595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New prospects of nicotine dependence treatment--vaccines].
    Goniewicz ML; Koszowski B; Czogała J; Zymełka A
    Przegl Lek; 2006; 63(10):1114-8. PubMed ID: 17288232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine conjugate vaccine as a novel approach to smoking cessation.
    Ottney AR
    Pharmacotherapy; 2011 Jul; 31(7):703-13. PubMed ID: 21923458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting nicotine addiction: the possibility of a therapeutic vaccine.
    Escobar-Chávez JJ; Domínguez-Delgado CL; Rodríguez-Cruz IM
    Drug Des Devel Ther; 2011; 5():211-24. PubMed ID: 21607018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine vaccines for smoking cessation.
    Murtagh J; Foerster V
    Issues Emerg Health Technol; 2007 Sep; (103):1-4. PubMed ID: 17896445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity.
    Maurer P; Jennings GT; Willers J; Rohner F; Lindman Y; Roubicek K; Renner WA; Müller P; Bachmann MF
    Eur J Immunol; 2005 Jul; 35(7):2031-40. PubMed ID: 15971275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.
    LeSage MG; Keyler DE; Pentel PR
    AAPS J; 2006 Feb; 8(1):E65-75. PubMed ID: 16584135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.